RMD · NYSE · ·
$238,99+%0,212 Kas kapanış
30 Eylül 2026 tarihine kadarki rakamlar, 30 Ekim 2026 tarihinde sunulan 10-Q raporundan
Just reported
From Resmed's results release of 29 Ekim 2026; its quarterly report has since been filed.
Actual
$1,41B
+%5,9 y/y
-%3,3 q/q
Guided
—
No guide given
Actual
$2,92
+%23 y/y
+%11 q/q
Guided
—
No guide given
Actual
$453M
+%1,4 y/y
+%1,0 q/q
Guided
—
No guide given
Full year 2027
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Resmed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Gelir payları quarter ended 2026-03-31 dönemi için tahmindir; resmî bir bildirimden alınmış rakamlar değildir.
AirSense 11
A connected machine that delivers continuous or automatically adjusted air pressure to treat sleep apnea.
AirCurve 11
A bilevel breathing machine that provides different pressure levels for breathing in and out, for people needing more support or with complex breathing disorders.
Astral ventilators
Ventilators that provide breathing support, including for people receiving care at home.
AirTouch N30i, AirTouch F30i, and AirFit F40 masks
Masks that connect a person to a breathing machine during sleep; the named models include fabric and silicone designs.
myAir and AirView
Software for patients to engage with their sleep treatment and for providers to connect with and support patients.
Brightree and MEDIFOX DAN
Software products for residential care and home medical equipment providers.
ResMed makes devices that help people breathe during sleep and ventilators for people who need breathing support. It also sells masks and software for patients, medical equipment providers, and residential care providers. Its sleep products include machines that connect with patient and provider software.
Resmed Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.
ResMed sells breathing machines and masks for sleep apnea and other breathing disorders to patients through medical equipment providers.
Grade B+
Fiyatın altındaki şerit, her tarihteki notu gösterir; yalnızca o tarihe kadar yayımlanmış belgelerden hesaplanır.
Resmed Inc. şirketinin not geçmişinin 41 çeyreğinden 2 tanesi gösteriliyor. Diğer 39 çeyrek Ekim 2016 tarihine kadar uzanıyor.